LV10391A - Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai - Google Patents

Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai

Info

Publication number
LV10391A
LV10391A LV920169A LV920169A LV10391A LV 10391 A LV10391 A LV 10391A LV 920169 A LV920169 A LV 920169A LV 920169 A LV920169 A LV 920169A LV 10391 A LV10391 A LV 10391A
Authority
LV
Latvia
Prior art keywords
alkylphosphorus
compounds
treatment
psoriasis diseases
psoriasis
Prior art date
Application number
LV920169A
Other languages
English (en)
Other versions
LV10391B (en
Inventor
Hansjoerg Eibl
Clemens Unger
Juergen Engel
Original Assignee
Asta Medica Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV10391(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Medica Ag, Max Planck Gesellschaft filed Critical Asta Medica Ag
Publication of LV10391A publication Critical patent/LV10391A/lv
Publication of LV10391B publication Critical patent/LV10391B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-92-169A 1989-09-27 1992-10-27 Use of derivatives of alkylphosphoric acid for healing of psoriasis LV10391B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (2)

Publication Number Publication Date
LV10391A true LV10391A (lv) 1995-02-20
LV10391B LV10391B (en) 1995-10-20

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-169A LV10391B (en) 1989-09-27 1992-10-27 Use of derivatives of alkylphosphoric acid for healing of psoriasis

Country Status (17)

Country Link
EP (2) EP0916343A1 (lv)
JP (1) JP3176615B2 (lv)
CA (1) CA2026278C (lv)
DD (1) DD298052A5 (lv)
DE (1) DE4029747C2 (lv)
EG (1) EG19338A (lv)
FI (1) FI904726A0 (lv)
HU (1) HU209589B (lv)
IE (1) IE903464A1 (lv)
LT (1) LT3804B (lv)
LV (1) LV10391B (lv)
MC (1) MC2150A1 (lv)
NO (1) NO904184L (lv)
PT (1) PT95422B (lv)
RU (1) RU1837877C (lv)
UA (1) UA19335A (lv)
ZA (1) ZA907702B (lv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4233044A1 (de) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipidderivate, die höhere Elemente der V. Hauptgruppe enthalten
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
SK284839B6 (sk) * 1998-01-22 2005-12-01 Zentaris Gmbh Použitie miltefozínu na výrobu lieku a farmaceutická kombinácia na liečenie leishmanózy
DE102006004821B4 (de) * 2006-01-30 2020-12-10 Cuma Kilic Sammelbehältnis für Abfall und Bauschutt
EP2451460B1 (en) * 2009-07-09 2017-10-25 Paul Meng Liquid pharmaceutical form of hexadecylphosphocholine and method of preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
IE59778B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicament with anti-tumour action containing hexadecylphosphocholine
DE3829899C2 (de) * 1988-09-02 1994-12-15 Reutter Werner Glyceringlycophosphatide und diese enthaltende pharmazeutische Mittel zur Bekämpfung von Hauterkrankungen

Also Published As

Publication number Publication date
HU209589B (en) 1994-08-29
EG19338A (en) 1994-12-30
JP3176615B2 (ja) 2001-06-18
JPH03130228A (ja) 1991-06-04
LT3804B (en) 1996-03-25
EP0419998A3 (en) 1991-10-23
RU1837877C (ru) 1993-08-30
IE903464A1 (en) 1991-04-10
ZA907702B (en) 1991-07-31
NO904184L (no) 1991-04-02
UA19335A (uk) 1997-12-25
EP0916343A1 (de) 1999-05-19
LTIP1488A (en) 1995-06-26
CA2026278A1 (en) 1991-03-28
EP0419998A2 (de) 1991-04-03
HUT55992A (en) 1991-07-29
DE4029747C2 (de) 2003-10-02
DE4029747A1 (de) 1991-04-11
PT95422A (pt) 1991-05-22
LV10391B (en) 1995-10-20
FI904726A0 (fi) 1990-09-26
DD298052A5 (de) 1992-02-06
CA2026278C (en) 1996-04-30
MC2150A1 (fr) 1992-03-10
NO904184D0 (no) 1990-09-26
PT95422B (pt) 1997-07-31
HU906233D0 (en) 1991-03-28

Similar Documents

Publication Publication Date Title
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
NO179353C (no) Anvendelse av mikrobicide forbindelser av dimetylamin-epiklorhydrinaminer
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
FI945441A0 (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
IS1667B (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkumbis-aza-bísýklískum efnasamböndum
IT8867534A0 (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
BG94738A (bg) Използване на разтвор на йод за лечение на заболявания, свързани с йодна недостатъчност
AU6142186A (en) Use of melatonin or related compounds for the treatment of psoriasis
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
KR930702990A (ko) 섬유성 질병 치료제로서의 프로스타사이클린- 및 카르바사이클린 유도체
IT8420682A1 (it) "Procedimento per il trattamento di articoli di maglieria"
NO920983L (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
DK484186A (da) Fremgangsmaade til fremstilling af et praeparat til behandling af psoriasis
NO172115C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bronkospasmolytiske forbindelser
FI91069B (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
NO173871C (no) Fremgangsmaate for fremstilling av penemforbindelser
ZA86370B (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
IT8212678A0 (it) Preparato per il trattamento del l acne
IL99236A0 (en) Pharmaceutical composition for the topical treatment of psoriasis
KR890701106A (ko) 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도
NO920694L (no) Fremgangsmaate for etterbehandling av tremasse
IT8419940A0 (it) Nuovi medicinali per il trattamento di malattie cardiache.
NO922413L (no) Utstyr for bruk i diagnostisering av sykdommer